Behavioral and emerging pharmacologic treatment options for cognitive impairment in schizophrenia.

Vinogradov S, Schulz SC. Behavioral and emerging pharmacologic treatment options for cognitive impairment in schizophrenia. J Clin Psychiatry. 2016;77 Suppl 2:12-6. DOI: 10.4088/JCP.14074su1c.03. PubMed PMID: 26919053.

Ditching our simplistic systems for categorising mental health problems.

Dudleston KE. Ditching our simplistic systems for categorising mental health problems. BMJ. 2016;352:i1044. DOI: 10.1136/bmj.i1044. PubMed PMID: 26905081.

Rebranding schizophrenia is unlikely to reduce stigma.

Hamilton I. Rebranding schizophrenia is unlikely to reduce stigma. BMJ. 2016;352:i1043. DOI: 10.1136/bmj.i1043. PubMed PMID: 26905294.

"Schizophrenia" is a useful concept.

Lawrie SM. "Schizophrenia" is a useful concept. BMJ. 2016;352:i1046. DOI: 10.1136/bmj.i1046. PubMed PMID: 26908463.

Schizophrenia: changing the name and broadening the concept is problematic.

Sommer IE, Carpenter WT. Schizophrenia: changing the name and broadening the concept is problematic. BMJ. 2016;352:i1080. DOI: 10.1136/bmj.i1080. PubMed PMID: 26908503.

Mechanism of action of brexpiprazole: comparison with aripiprazole.

Stahl SM. Mechanism of action of brexpiprazole: comparison with aripiprazole. CNS Spectr. 2016;21(1):1-6. DOI: 10.1017/S1092852915000954. PubMed PMID: 26899451.

Adjunctive treatment with low-dosage pramipexole for risperidone-associated hyperprolactinemia and sexual dysfunction in a male patient with schizophrenia.

Ishitobi M, Kosaka H, Shukunami K-ichi, Murata T, Wada Y. Adjunctive treatment with low-dosage pramipexole for risperidone-associated hyperprolactinemia and sexual dysfunction in a male patient with schizophrenia. J Clin Psychopharmacol. 2011;31(2):243-5. DOI: 10.1097/JCP.0b013e31820f4fbd. PubMed PMID: 21364336.

Olanzapine use in women with antipsychotic-induced hyperprolactinemia.

Canuso CM, Hanau M, Jhamb KK, Green AI. Olanzapine use in women with antipsychotic-induced hyperprolactinemia. AJP. 1998;155(10):1458. DOI: 10.1176/ajp.155.10.1458. PubMed PMID: 9766782.

Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment.

Montgomery J, Winterbottom E, Jessani M, Kohegyi E, Fulmer J, Seamonds B, et al. Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment. J Clin Psychiatry. 2004;65(11):1491-8. PubMed PMID: 15554761.

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis.

Kapur S, Seeman P. Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis. Am J Psychiatry. 2001;158(3):360-9. DOI: 10.1176/appi.ajp.158.3.360. PubMed PMID: 11229973.